Health
Thai study looks at CoronaVac vaccine vs. natural immunity to SARS-COV-2 variants – News-Medical.Net
A new study evaluates the efficacy of vaccine- and infection-induced antibodies against SARS-CoV-2 variants.
The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is a novel coronavirus that was first reported in Wuhan, China in December 2019. SARS-CoV-2, which has a very high rate of transmission, is the causal agent of the coronavirus disease 2019…
Continue Reading
-
Noosa News21 hours agoIncrease in extreme weather events poses ‘substantial risk’ to blood supplies, researchers warn
-
Noosa News11 hours agoAustralians tell ABC’s Your Say how they saw the second leaders debate
-
General7 hours agoNT Coalition candidate Lisa Siebert diverges from Jacinta Nampijinpa Price on royal commission call
-
Noosa News16 hours agoManjimup engineer turns previously wasted avocados into liquid gold